EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4

Lu Zhang, Zhengying Fang, Qingqing Zhu, Shumin Yang, Jia Fu, Zeguo Sun, Geming Lu, Chengguo Wei, Zhi Zhang, Kyung Lee, Yifei Zhong, Ruijie Liu und 1 weitere

Advanced Science · 2024-08 · 11 (29)

DOI: 10.1002/advs.202309642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.05.2024. Verfasst von Lu Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, Box 1243, USA. Hauptthemen laut MEDLINE: ADP-Ribosylation Factors, Diabetic Nephropathies, Steroid Hydroxylases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NIDDK, BLRD VA, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesterol 25‐hydroxylase (CH25H), an enzyme involved in cholesterol metabolism, regulates inflammatory responses and lipid metabolism. However, its role in kidney disease is not known. The author found that CH25H transcript is expressed mostly in glomerular and peritubular endothelial cells and that its expression increased in human and mouse diabetic kidneys. Global deletion of Ch25h in Lepr db/db mice aggravated diabetic kidney disease (DKD), which is associated with increased endothelial cell apoptosis. Treatment of 25‐hydroxycholesterol (25‐HC), the product of CH25H, alleviated kidney injury in Lepr db/db mice. Mechanistically, 25‐HC binds to GTP‐binding protein ADP‐ribosylation factor 4 (ARF4), an essential protein required for maintaining protein transport in the Golgi apparatus. Interestingly, ARF4's GTPase‐activating protein ASAP1 is also predominantly expressed in endothelial cells and its expression increased in DKD. Suppression of ARF4 activity by deleting ARF4 or overexpressing ASAP1 results in endothelial cell death. These results indicate that 25‐HC binds ARF4 to inhibit its interaction with ASAP1, and thereby resulting in enhanced ARF4 activity to confer renoprotection. Therefore, treatment of 25‐HC improves kidney injury in DKD in part by restoring ARF4 activity to maintain endothelial cell survival. This study provides a novel mechanism and a potential new therapy for DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADP-Ribosylation FactorsDiabetic NephropathiesSteroid HydroxylasesAnimalsHumansMaleMiceDisease Models, AnimalHydroxycholesterolsMice, Inbred C57BL

Stichwörter der Autor:innen

diabetic kidney diseasesglomerular endothelial cellsgolgi apparatus

Substanzen

25-hydroxycholesterolADP-Ribosylation FactorsARF4 protein, mousecholesterol 25-hydroxylaseHydroxycholesterolsSteroid HydroxylasesARF4 protein, human

Autor:innen und Institutionen

  • Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, Box 1243, USA.
  • Division of Endocrinology, Diabetes and Bone Diseases, Icahn School of Medicine at Mount Sinai, Diabetes, Obesity and Metabolism Institute, One Gustave L. Levy Place, New York, NY, 10029, USA.
  • Département de Génétique Laboratoire national de santé Dudelange, Dudelange, L-3555, Luxembourg.
  • Division of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai, 200032, China.
  • Renal Section, James J Peter Veterans Administration Medical Center, Bronx, NY, 10468, USA.

ORCID-Profile: John Cijiang He

Förderung

  • NIH/NIDDK
  • BLRD VA
  • NIDDK NIH HHS
  • VA Merit Award
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Zhang, L., Fang, Z., Zhu, Q., Yang, S., Fu, J., Sun, Z., Lu, G., Wei, C., Zhang, Z., Lee, K., Zhong, Y., Liu, R., & He, J. C. (2024). Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4. Advanced Science, 11(29). https://doi.org/10.1002/advs.202309642

Vancouver

Zhang L, Fang Z, Zhu Q, Yang S, Fu J, Sun Z, et al. Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4. Advanced Science. 2024;11(29). doi:10.1002/advs.202309642

BibTeX
@article{Zhang2024,
  author = {Zhang, Lu and Fang, Zhengying and Zhu, Qingqing and Yang, Shumin and Fu, Jia and Sun, Zeguo and Lu, Geming and Wei, Chengguo and Zhang, Zhi and Lee, Kyung and Zhong, Yifei and Liu, Ruijie and He, John Cijiang},
  title = {Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {29},
  doi = {10.1002/advs.202309642}
}
Kostenlos starten →